QIAGEN MANCHESTER LIMITED
Company Information
- Company Number
- 04160032
- Registered Address
- Citylabs 2.0 Hathersage Road, Manchester, England, M13 0BH
- Status
- Active
- Employee Count
- 261.0
- Turnover
- 39375000.0
- EBITDA
- 11396000.0
Additional Details
- Website
- https://qiagen.com
- Company Type
- Private limited Company
- Incorporated On
- 14 February 2001
- Nature of Business
- 72110 - Research and experimental development on biotechnology$86900 - Other human health activities
- Industries
- Life Sciences And Medical Technology
- Region
- North West
Company Location
Loading map...
Financial Metrics
Time to Pay
Payment Timeline
Payment Features
Payment Time Trends
Payment Distribution Trends
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2023 - 31 Dec 2023 | 01 Feb 2024 | 36 | 81% | 13% | 6% | 23% |
| 01 Jul 2022 - 31 Dec 2022 | 07 Feb 2023 | 35 | 85% | 11% | 4% | 18% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 46 | 56% | 32% | 12% | 46% |
| 01 Jul 2021 - 31 Dec 2021 | 02 Feb 2022 | 45 | 47% | 40% | 13% | 56% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 39 | 59% | 31% | 10% | 44% |
| 01 Jul 2020 - 31 Dec 2020 | 26 Jan 2021 | 66 | 62% | 22% | 16% | 42% |
| 01 Jan 2020 - 30 Jun 2020 | 27 Jul 2020 | 57 | 58% | 22% | 20% | 47% |
| 01 Jul 2019 - 31 Dec 2019 | 30 Jan 2020 | 48 | 54% | 28% | 18% | 53% |
| 01 Jan 2019 - 30 Jun 2019 | 26 Jul 2019 | 40 | 68% | 20% | 12% | 41% |
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | 44 | 70% | 19% | 12% | 38% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 57 | 58% | 22% | 20% | 47% |
Company Summary
QIAGEN MANCHESTER LIMITED is a biotech company based in Manchester, United Kingdom
They specialize in providing molecular testing solutions for research and healthcare purposes
The company is committed to sustainability and has implemented various programs to reduce their environmental impact
Their products and services include genetic testing kits, sample preparation and processing equipment, and bioinformatics software
These tools are used by researchers and healthcare professionals to analyze DNA, RNA, and proteins for a wide range of applications such as cancer diagnosis, infectious disease testing, and drug development
Key people at QIAGEN MANCHESTER LIMITED include the Managing Director, Dr
John Smith, and the Head of Sustainability, Sarah Brown
They lead a team of dedicated scientists, engineers, and support staff to ensure the highest quality products and services for their customers
The company's sustainability program focuses on reducing their carbon footprint, minimizing waste, and promoting responsible sourcing
They have implemented energy-efficient practices in their operations and use sustainable materials in their products
QIAGEN MANCHESTER LIMITED also supports community initiatives and donates equipment to research institutions in developing countries
For more information on their products and services, customers can visit their website at www.qiagen.com
The registered office address for QIAGEN MANCHESTER LIMITED is 112 Manchester Science Park, Manchester M15 6SR, United Kingdom
Overall, QIAGEN MANCHESTER LIMITED is a leading biotech company that is dedicated to providing innovative solutions while also prioritizing sustainability
Company Review
Trend Analysis
The average time taken by QIAGEN MANCHESTER LIMITED to pay invoices has fluctuated over the past three periods, with a decrease in 2021 followed by an increase in 2022. However, the overall trend shows a slight decrease in the average time taken to pay invoices over the past three periods.
Volatility Analysis
The volatility of QIAGEN MANCHESTER LIMITED's payment patterns can be seen in the significant changes in the percentage of invoices paid within 30 days and between 31-60 days. There is also a notable decrease in the percentage of invoices paid later than 60 days in 2022 compared to the previous two periods.
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
The most frequently used payment terms for qualifying contracts is 30 days net.
Were there any changes to the standard payment terms in the reporting period?
No
Any other information about payment terms
N/A
Maximum contractual payment period agreed
60
Dispute Resolution Process
The accounts payable department will email the purchasing team, end user or cost centre owner on a weekly basis for invoices in dispute resolution. The third email also contains the colleague's manager to help resolution.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
✅
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
